OpenURL Connection Search

Select item for more details and to access through your institution.

Aberrant dopamine transporter and functional connectivity patterns in LRRK2 and GBA mutation carriers.
Published in:
NPJ Parkinson's Disease, 2022, v. 8, n. 1, p. 1, doi. 10.1038/s41531-022-00285-z
By:
- Droby, Amgad;
- Artzi, Moran;
- Lerman, Hedva;
- Hutchison, R. Matthew;
- Bashat, Dafna Ben;
- Omer, Nurit;
- Gurevich, Tanya;
- Orr-Urtreger, Avi;
- Cohen, Batsheva;
- Cedarbaum, Jesse M.;
- Sapir, Einat Even;
- Giladi, Nir;
- Mirelman, Anat;
- Thaler, Avner
Publication type:
Article
The Influence of GBA and LRRK2 on Mood Disorders in Parkinson's Disease.
Published in:
Movement Disorders Clinical Practice, 2023, v. 10, n. 4, p. 606, doi. 10.1002/mdc3.13722
By:
- DeBroff, Jake;
- Omer, Nurit;
- Cohen, Batsheva;
- Giladi, Nir;
- Kestenbaum, Meir;
- Shirvan, Julia C.;
- Cedarbaum, Jesse M.;
- Gana‐Weisz, Mali;
- Goldstein, Orly;
- Orr‐Urtreger, Avi;
- Mirelman, Anat;
- Thaler, Avner
Publication type:
Article
Evaluating dopamine transporter imaging as an enrichment biomarker in a phase 2 Parkinson's disease trial.
Published in:
2021
By:
- Hutchison, R. Matthew;
- Evans, Karleyton C.;
- Fox, Tara;
- Yang, Minhua;
- Barakos, Jerome;
- Bedell, Barry J.;
- Cedarbaum, Jesse M.;
- Brys, Miroslaw;
- Siderowf, Andrew;
- Lang, Anthony E.
Publication type:
journal article
Evaluating dopamine transporter imaging as an enrichment biomarker in a phase 2 Parkinson's disease trial.
Published in:
BMC Neurology, 2021, v. 21, n. 1, p. 1, doi. 10.1186/s12883-021-02470-8
By:
- Hutchison, R. Matthew;
- Evans, Karleyton C.;
- Fox, Tara;
- Yang, Minhua;
- Barakos, Jerome;
- Bedell, Barry J.;
- Cedarbaum, Jesse M.;
- Brys, Miroslaw;
- Siderowf, Andrew;
- Lang, Anthony E.
Publication type:
Article
Perspective: The Alzheimer's Disease Neuroimaging Initiative and the role and contributions of the Private Partner Scientific Board (PPSB).
Published in:
Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2015, v. 11, n. 7, p. 840, doi. 10.1016/j.jalz.2015.04.001
By:
- Liu, Enchi;
- Luthman, Johan;
- Cedarbaum, Jesse M.;
- Schmidt, Mark E.;
- Cole, Patricia E.;
- Hendrix, James;
- Carrillo, Maria C.;
- Jones-Davis, Dorothy;
- Tarver, Erika;
- Novak, Gerald;
- De Santi, Susan;
- Soares, Holly D.;
- Potter, William Z.;
- Siemers, Eric;
- Schwarz, Adam J.
Publication type:
Article
Rationale for use of the Clinical Dementia Rating Sum of Boxes as a primary outcome measure for Alzheimer’s disease clinical trials
Published in:
Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2013, v. 9, n. s1, p. S45, doi. 10.1016/j.jalz.2011.11.002
By:
- Cedarbaum, Jesse M.;
- Jaros, Mark;
- Hernandez, Chito;
- Coley, Nicola;
- Andrieu, Sandrine;
- Grundman, Michael;
- Vellas, Bruno
Publication type:
Article
Mild cognitive impairment: Disparity of incidence and prevalence estimates
Published in:
Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2012, v. 8, n. 1, p. 14, doi. 10.1016/j.jalz.2011.01.002
By:
- Ward, Alex;
- Arrighi, H. Michael;
- Michels, Shannon;
- Cedarbaum, Jesse M.
Publication type:
Article
Oral amyloid anti-aggregating agent ELND005 is measurable in CSF and brain of healthy adult men
Published in:
2009
By:
- Garzone, Pamela;
- Koller, Martin;
- Pastrak, Aleksandra;
- Jhee, Stanford S.;
- Ereshefsky, Larry;
- Moran, Samira;
- Cedarbaum, Jesse M.;
- Xu, Victor;
- Ross, Brian
Publication type:
Abstract
Rehabilitation Programs in the Management of Patients with Parkinson's Disease.
Published in:
Neurorehabilitation & Neural Repair, 1992, v. 6, n. 1, p. 7, doi. 10.1177/154596839200600102
By:
- MD, Jesse M. Cedarbaum;
- RN, Linda Toy;
- RN, Mary Silvestri;
- BA, Alison Green-Parsons;
- BA, Amy Harts;
- MD, Fletcher H. McDowell
Publication type:
Article
Afferent projections to the rat locus coeruleus as determined by a retrograde tracing technique.
Published in:
Journal of Comparative Neurology, 1978, v. 178, n. 1, p. 1, doi. 10.1002/cne.901780102
By:
- Cedarbaum, Jesse M.;
- Aghajanian, George K.
Publication type:
Article
Sustained-release (+)-PHNO [MK-458 (HPMC)] in the treatment of Parkinson's disease: Evidence for tolerance to a selective D<sub>2</sub>-receptor agonist administered as a long-acting formulation.
Published in:
Movement Disorders, 1990, v. 5, n. 4, p. 298, doi. 10.1002/mds.870050407
By:
- Cedarbaum, Jesse M.;
- Clark, Mary;
- Toy, Linda H.;
- Green-Parsons, Alison
Publication type:
Article
Letters to the editor.
Published in:
Movement Disorders, 1990, v. 5, n. 3, p. 263, doi. 10.1002/mds.870050317
By:
- Decina, Paolo;
- Caracci, Giovanni;
- Scapicchio, Pier Luigi;
- Goetz, Christopher G.;
- Tanner, Caroline M.;
- Cohen, Jack A.;
- Thelen, Jean A.;
- Carroll, V. Susan;
- Klawans, Harold L.;
- Fariello, Ruggero G.;
- Walker, Francis O.;
- Walker, J. Michael;
- Matsumoto, Rae R.;
- Bowen, Wayne D.;
- Cedarbaum, Jesse M.;
- Crossman, A. R.
Publication type:
Article
Metabolic syndrome does not influence the phenotype of LRRK2 and GBA related Parkinson's disease.
Published in:
Scientific Reports, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41598-020-66319-9
By:
- Thaler, Avner;
- Shenhar-Tsarfaty, Shani;
- Shaked, Yanay;
- Gurevich, Tanya;
- Omer, Nurit;
- Bar-Shira, Anat;
- Gana-Weisz, Mali;
- Goldstein, Orly;
- Kestenbaum, Meir;
- Cedarbaum, Jesse M.;
- Orr-Urtreger, Avi;
- Giladi, Nir;
- Mirelman, Anat
Publication type:
Article
Neuromelanin and T<sub>2</sub>*-MRI for the assessment of genetically at-risk, prodromal, and symptomatic Parkinson's disease.
Published in:
NPJ Parkinson's Disease, 2022, v. 8, n. 1, p. 1, doi. 10.1038/s41531-022-00405-9
By:
- Ben Bashat, Dafna;
- Thaler, Avner;
- Lerman Shacham, Hedva;
- Even-Sapir, Einat;
- Hutchison, Matthew;
- Evans, Karleyton C.;
- Orr-Urterger, Avi;
- Cedarbaum, Jesse M.;
- Droby, Amgad;
- Giladi, Nir;
- Mirelman, Anat;
- Artzi, Moran
Publication type:
Article
Fletcher H. McDowell, MD, 1923-2017.
Published in:
2017
By:
- Cedarbaum, Jesse M.;
- Aisen, Mindy;
- Volpe, Bruce T.
Publication type:
Editorial
Biochemical markers for severity and risk in GBA and LRRK2 Parkinson's disease.
Published in:
Journal of Neurology, 2021, v. 268, n. 4, p. 1517, doi. 10.1007/s00415-020-10325-4
By:
- Thaler, Avner;
- Omer, Nurit;
- Giladi, Nir;
- Gurevich, Tanya;
- Bar-Shira, Anat;
- Gana-Weisz, Mali;
- Goldstein, Orly;
- Kestenbaum, Meir;
- Cedarbaum, Jesse M.;
- Orr-Urtreger, Avi;
- Shenhar-Tsarfaty, Shani;
- Mirelman, Anat
Publication type:
Article
Application of longitudinal item response theory models to modeling Parkinson's disease progression.
Published in:
CPT: Pharmacometrics & Systems Pharmacology, 2022, v. 11, n. 10, p. 1382, doi. 10.1002/psp4.12853
By:
- Zou, Haotian;
- Aggarwal, Varun;
- Stebbins, Glenn T.;
- Müller, Martijn L. T. M.;
- Cedarbaum, Jesse M.;
- Pedata, Anne;
- Stephenson, Diane;
- Simuni, Tanya;
- Luo, Sheng
Publication type:
Article
Validity of the Short Weekly Calendar Planning Activity in patients with Parkinson disease and nonmanifesting LRRK2 and GBA carriers.
Published in:
European Journal of Neurology, 2024, v. 31, n. 8, p. 1, doi. 10.1111/ene.16327
By:
- Schejter‐Margalit, Tamara;
- Binyamin, Noam Ben;
- Thaler, Avner;
- Maidan, Inbal;
- Cedarbaum, Jesse M.;
- Orr‐Urtreger, Avi;
- Gana Weisz, Mali;
- Goldstein, Orly;
- Giladi, Nir;
- Mirelman, Anat;
- Kizony, Rachel
Publication type:
Article
Digital Mobility Measures: A Window into Real‐World Severity and Progression of Parkinson's Disease.
Published in:
Movement Disorders, 2024, v. 39, n. 2, p. 328, doi. 10.1002/mds.29689
By:
- Mirelman, Anat;
- Volkov, Jana;
- Salomon, Amit;
- Gazit, Eran;
- Nieuwboer, Alice;
- Rochester, Lynn;
- Del Din, Silvia;
- Avanzino, Laura;
- Pelosin, Elisa;
- Bloem, Bastiaan R.;
- Della Croce, Ugo;
- Cereatti, Andrea;
- Thaler, Avner;
- Roggen, Daniel;
- Mazza, Claudia;
- Shirvan, Julia;
- Cedarbaum, Jesse M.;
- Giladi, Nir;
- Hausdorff, Jeffrey M.
Publication type:
Article
Glucocerebrosidase Activity Is Not Associated with Parkinson's Disease Risk or Severity.
Published in:
Movement Disorders, 2022, v. 37, n. 3, p. 651, doi. 10.1002/mds.28929
By:
- Omer, Nurit;
- Giladi, Nir;
- Gurevich, Tanya;
- Bar‐Shira, Anat;
- Gana‐Weisz, Mali;
- Glinka, Tal;
- Goldstein, Orly;
- Kestenbaum, Meir;
- Cedarbaum, Jesse M.;
- Mabrouk, Omar S.;
- Fraser, Kyle B.;
- Shirvan, Julia C.;
- Orr‐Urtreger, Avi;
- Mirelman, Anat;
- Thaler, Avner
Publication type:
Article
Glucocerebrosidase Activity is not Associated with Parkinson's Disease Risk or Severity.
Published in:
Movement Disorders, 2022, v. 37, n. 1, p. 190, doi. 10.1002/mds.28792
By:
- Omer, Nurit;
- Giladi, Nir;
- Gurevich, Tanya;
- Bar‐Shira, Anat;
- Gana‐Weisz, Mali;
- Glinka, Tal;
- Goldstein, Orly;
- Kestenbaum, Meir;
- Cedarbaum, Jesse M.;
- Mabrouk, Omar S.;
- Fraser, Kyle B.;
- Shirvan, Julia C.;
- Orr‐Urtreger, Avi;
- Mirelman, Anat;
- Thaler, Avner
Publication type:
Article
Longitudinal Changes in Neuromelanin MRI Signal in Parkinson's Disease: A Progression Marker.
Published in:
Movement Disorders, 2021, v. 36, n. 7, p. 1592, doi. 10.1002/mds.28531
By:
- Gaurav, Rahul;
- Yahia‐Cherif, Lydia;
- Pyatigorskaya, Nadya;
- Mangone, Graziella;
- Biondetti, Emma;
- Valabrègue, Romain;
- Ewenczyk, Claire;
- Hutchison, R. Matthew;
- Cedarbaum, Jesse M.;
- Corvol, Jean‐Christophe;
- Vidailhet, Marie;
- Lehéricy, Stéphane
Publication type:
Article
A Possible Modifying Effect of the G2019S Mutation in the LRRK2 Gene on GBA Parkinson's Disease.
Published in:
2020
By:
- Omer, Nurit;
- Giladi, Nir;
- Gurevich, Tanya;
- Bar‐Shira, Anat;
- Gana‐Weisz, Mali;
- Goldstein, Orly;
- Kestenbaum, Meir;
- Cedarbaum, Jesse M.;
- Orr‐Urtreger, Avi;
- Mirelman, Anat;
- Thaler, Avner;
- Bar-Shira, Anat;
- Gana-Weisz, Mali;
- Orr-Urtreger, Avi
Publication type:
journal article
Tossing and Turning in Bed: Nocturnal Movements in Parkinson's Disease.
Published in:
2020
By:
- Mirelman, Anat;
- Hillel, Inbar;
- Rochester, Lynn;
- Del Din, Silvia;
- Bloem, Bastiaan R.;
- Avanzino, Laura;
- Nieuwboer, Alice;
- Maidan, Inbal;
- Herman, Talia;
- Thaler, Avner;
- Gurevich, Tanya;
- Kestenbaum, Meir;
- Orr‐Urtreger, Avi;
- Brys, Mirek;
- Cedarbaum, Jesse M.;
- Giladi, Nir;
- Hausdorff, Jeffrey M.;
- Orr-Urtreger, Avi
Publication type:
journal article
Randomized phase I clinical trial of anti-α-synuclein antibody BIIB054.
Published in:
2019
By:
- Brys, Miroslaw;
- Fanning, Laura;
- Hung, Serena;
- Ellenbogen, Aaron;
- Penner, Natalia;
- Yang, Minhua;
- Welch, Mackenzie;
- Koenig, Erica;
- David, Eric;
- Fox, Tara;
- Makh, Shavy;
- Aldred, Jason;
- Goodman, Ira;
- Pepinsky, Blake;
- Liu, YuTing;
- Graham, Danielle;
- Weihofen, Andreas;
- Cedarbaum, Jesse M.
Publication type:
journal article
Digital technologies as biomarkers, clinical outcomes assessment, and recruitment tools in Alzheimer's disease clinical trials.
Published in:
Alzheimer's & Dementia: Translational Research & Clinical Interventions, 2018, v. 4, n. 1, p. 234, doi. 10.1016/j.trci.2018.04.003
By:
- Gold, Michael;
- Amatniek, Joan;
- Carrillo, Maria C.;
- Cedarbaum, Jesse M.;
- Hendrix, James A.;
- Miller, Bradley B.;
- Robillard, Julie M.;
- Rice, J. Jeremy;
- Soares, Holly;
- Tome, Maria B.;
- Tarnanas, Ioannis;
- Vargas, Gabriel;
- Bain, Lisa J.;
- Czaja, Sara J.
Publication type:
Article
Physiological characterization of taxol-induced large-fiber sensory neuropathy in the rat.
Published in:
Annals of Neurology, 1998, v. 43, n. 1, p. 46, doi. 10.1002/ana.410430111
By:
- Cliffer, Kenneth D.;
- Siuciak, Judith A.;
- Carson, Susan R.;
- Radley, Heather E.;
- Park, John S.;
- Lewis, Dacie R.;
- Zlotchenko, Elizabeth;
- Nguyen, Trang;
- Garcia, Karen;
- Tonra, James R.;
- Stambler, Nancy;
- Cedarbaum, Jesse M.;
- Bodine, Sue C.;
- Lindsay, Ronald M.;
- Distefano, Peter S.
Publication type:
Article
Re: Pharmacokinetics and pharmacodynamics of rHCNTF in rodents.
Published in:
Annals of Neurology, 1996, v. 39, n. 4, p. 552, doi. 10.1002/ana.410390420
By:
- Cedarbaum, Jesse M.;
- Distcfano, Peter S.;
- Lakings, Duane B.;
- Lindsay, Ronald M.
Publication type:
Article
Effects of brain-derived neurotrophic factor on motor dysfunction in wobbler mouse motor neuron disease.
Published in:
Annals of Neurology, 1995, v. 37, n. 4, p. 505, doi. 10.1002/ana.410370413
By:
- Ikeda, Ken;
- Klinkosz, Bogdan;
- Greene, Tom;
- Cedarbaum, Jesse M.;
- Wong, Vivien;
- Lindsay, Ronald M.;
- Mitsumoto, Hiroshi
Publication type:
Article
Histometric effects of ciliary neurotrophic factor in wobbler mouse motor neuron disease.
Published in:
Annals of Neurology, 1995, v. 37, n. 1, p. 47, doi. 10.1002/ana.410370110
By:
- Ikeda, Ken;
- Wong, Vivien;
- Holmlund, Thomas H.;
- Greene, Tom;
- Cedarbaum, Jesse M.;
- Lindsay, Ronald M.;
- Mitsumoto, Hiroshi
Publication type:
Article
The effects of ciliary neurotrophic factor on motor dysfunction in wobbler mouse motor neuron disease.
Published in:
Annals of Neurology, 1994, v. 36, n. 2, p. 142, doi. 10.1002/ana.410360205
By:
- Mitsumoto, Hiroshi;
- Ikeda, Ken;
- Holmlund, Tomas;
- Greene, Tom;
- Cedarbaum, Jesse M.;
- Wong, Vivien;
- Lindsay, Ronald M.
Publication type:
Article
3-O-methyldopa administration does not alter fluorodopa transport into the brain.
Published in:
1992
By:
- Guttman, Mark;
- Léger, Gabriel;
- Cedarbaum, Jesse M.;
- Reches, Avinoam;
- Woodward, William;
- Evans, Alan;
- Diksic, Mirko;
- Gjedde, Albert;
- Guttman, M;
- Léger, G;
- Cedarbaum, J M;
- Reches, A;
- Woodward, W;
- Evans, A;
- Diksic, M;
- Gjedde, A
Publication type:
journal article
General assay for phosphoproteins in cerebrospinal fluid: A candidate market for paraneoplastic cerebellar degeneration.
Published in:
Annals of Neurology, 1990, v. 28, n. 6, p. 829, doi. 10.1002/ana.410280616
By:
- Gandy, Samuel E.;
- Grebb, Jack A.;
- Rosen, Neal;
- Albert, Katherine A.;
- Devinsky, Orrin;
- Blumberg, Hilary;
- Anderson, Neil;
- Cedarbaum, Jesse M.;
- Porter, Roger J.;
- Sedvall, Göran;
- Posner, Jerome B.;
- Greengard, Paul
Publication type:
Article
Deficiency of glutamate dehydrogenase in postmortem brain samples from parkinsonian putamen.
Published in:
1990
By:
- Cedarbaum, Jesse M.;
- Sheu, K.-F. R.;
- Harding, Bradford J.;
- Blass, John P.;
- Javoy-Agid, France;
- Agid, Yves;
- Cedarbaum, J M;
- Sheu, K F;
- Harding, B J;
- Blass, J P;
- Javoy-Agid, F;
- Agid, Y
Publication type:
commentary
Parkinson's disease: Biochemistry, clinical pathology and treatment By W. Birkmayer and P. Riederer (translated by Gavin Reynolds with the assistance of Karl Blau and Lindsay Reynolds) New York, Springer-Verlag, 1983 160 pp, illustrated, $39.00.
Published in:
Annals of Neurology, 1984, v. 16, n. 5, p. 625, doi. 10.1002/ana.410160523
By:
- Cedarbaum, Jesse M.
Publication type:
Article
Lisuride and other dopamine agonists Edited by Donald B Calne, Reinhard Horomki Richard J McDonald and Wolfgang Wittke New York, Raven Press, 1983 553 pp. illustrated, $39.50.
Published in:
Annals of Neurology, 1984, v. 15, n. 2, p. 215, doi. 10.1002/ana.410150225
By:
- Cedarbaum, Jesse M.
Publication type:
Article
Targeted Therapies for Parkinson's Disease: From Genetics to the Clinic.
Published in:
2018
By:
- Sardi, S. Pablo;
- Cedarbaum, Jesse M.;
- Brundin, Patrik
Publication type:
journal article
Elephants, Parkinson's Disease, and Proof-of-Concept Clinical Trials.
Published in:
2018
By:
- Cedarbaum, Jesse M.
Publication type:
journal article
Letters to the Editor.
Published in:
Movement Disorders, 1997, v. 12, n. 4, p. 624, doi. 10.1002/mds.870120432
By:
- Perucca, E.;
- Marchioni, E.;
- Soragna, D.;
- Savoldi, F.;
- Bharucha, Kersi J.;
- Sethi, Kapil D.;
- Cedarbaum, Jesse M.;
- Pappert, Eric J.;
- Goetz, Christopher G.;
- Lipton, Jack W.;
- Ling, Z. D.;
- Stebbins, Glenn T.;
- Carvey, Paul M.;
- Lynch, T.;
- Fahn, S.;
- Louis, E. D.;
- Odel, J. G.
Publication type:
Article
Neurotrophin-3 improves functional constipation
Published in:
American Journal of Gastroenterology (Springer Nature), 2003, v. 98, n. 6, p. 1338, doi. 10.1111/j.1572-0241.2003.t01-1-07477.x
By:
- Parkman, Henry P.;
- Rao, Satish S.C.;
- Reynolds, James C.;
- Schiller, Lawrence R.;
- Wald, Arnold;
- Miner, Philip B.;
- Lembo, Anthony J.;
- Gordon, James M.;
- Drossman, Douglas A.;
- Waltzman, Lynn;
- Stambler, Nancy;
- Cedarbaum, Jesse M.
Publication type:
Article

Found: 40